A carregar...
A practical guide to the handling and administration of talimogene laherparepvec in Europe
Talimogene laherparepvec is a herpes simplex virus-1-based intralesional oncolytic immunotherapy and is the first oncolytic virus to be approved in Europe. It is indicated for the treatment of adults with unresectable melanoma that is regionally or distantly metastatic (stage IIIB, IIIC, and IVM1a)...
Na minha lista:
| Publicado no: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5546812/ https://ncbi.nlm.nih.gov/pubmed/28814886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S133699 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|